Explore the latest in prostate cancer, including recent screening guidelines and advances in management of localized and metastatic disease.
This cohort study describes patient- and surgeon-level sexual function outcomes among patients undergoing radical prostatectomy in the Michigan Urological Surgery Improvement Collaborative (MUSIC) and examines the association between surgeon case volume and sexual function outcomes.
This post hoc subgroup analysis of a cohort from a population-based randomized clinical trial investigates the outcomes of prostate-specific antigen screening for prostate cancer among men who concomitantly use statin drugs.
This cohort study assesses whether an independent association between treatment modality and posttreatment regret mediates functional outcomes among men with localized prostate cancer.
This cohort study using data from the COVID-19 and Cancer Consortium registry examines whether androgen deprivation therapy is associated with decreased rates of mortality within 30 days of COVID-19 diagnosis among patients with prostate cancer.
This cohort study uses deidentified claims data from Blue Cross Blue Shield beneficiaries aged 40 to 89 years to evaluate changes in rates of prostate-specific antigen testing after the 2017 revision of the US Preventive Services Task Force guideline on prostate cancer screening.
This qualitative study examines patient preferences among men with prostate cancer for communications from clinicians about life expectancy.
This cross-sectional study evaluates the representation of racial and ethnic minority groups in breast, prostate, lung, and colorectal cancer studies with a focus on precision medicine objectives.
This cohort study examines disparities based on race and ethnicity in prostate cancer screenings following elevated prostate-specific antigen levels among US men.
This diagnostic study examines the ability of an artificial intelligence–powered platform vs manual evaluation to accurately and efficiently detect, grade, and quantify prostate cancer and reduce interobserver variability among experienced pathologists.
This cohort study analyzes factors associated with the use of hypofractionated radiation therapy during the period from 2016 to 2019 and evaluates real-world patient-reported outcomes data for men with nonmetastatic prostate cancer receiving hypofractionated radiation therapy and conventional radiation therapy.
This single-arm diagnostic imaging trial assesses the accuracy of 68Ga-PSMA-11 positron emission tomographic imaging in detecting pelvic nodal metastases compared with histopathology.
This prognostic study examines the use of molecular profiling of luminal and basal tumors in estimation of survival in men with castration-resistant metastatic prostate cancer.
This case report describes a man in his 70s with a neuroendocrine carcinoma in the right frontal lobe during treatment for prostate cancer.
Customize your JAMA Network experience by selecting one or more topics from the list below.